Photo from Yüksel Ürün/X
Jan 12, 2024, 23:05
Yüksel Ürün: Radiographic and Clinical PFS as Surrogates for OS in Prostate Cancer shows promise in accelerating trials!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently posted on X:
“Radiographic & Clinical PFS as Surrogates for OS in Prostate Cancer shows promise in accelerating trials!
– However, it’s important to consider the limitations inherent in retrospective analyses and the need for prospective validation in different patient populations.
– It’s necessary to confirm these with different mechanisms, like ADT combined with new potent androgen receptor inhibitors.”
Read further.
Source: Yüksel Ürün/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12